col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

34 Results       Page 1

Microbiology Society: Journal of General Virology
  original article Date Title Authors   All Authors
1 [GO] 2022―May―04 Mutations within scavenger receptor cysteine-rich (SRCR) protein domain 5 of porcine CD163 involved in infection with porcine reproductive and respiratory syndrome virus (PRRS) Ana M. M. Stoian, Raymond R. R. Rowland, Alberto Brandariz-Nuñez
2 [GO] 2022―Apr―04 SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges Nazia Thakur, Giulia Gallo, Joseph Newman, Thomas P. Peacock, Luca Biasetti, Catherine N. Hall, et al. (+3)
3 [GO] 2022―Jan―11 Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2 Katarzyna Piadel, Amin Haybatollahi, Angus George Dalgleish, Peter Lawrence Smith
4 [GO] 2021―Nov―24 Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples Aleksander Szymczak, Natalia Jędruchniewicz, Alessandro Torelli, Agata Kaczmarzyk-Radka, Rosa Coluccio, Marlena Kłak, et al. (+7)
5 [GO] 2021―Nov―17 Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale Kelvinson Viana, Luis Zarpelon, Andre Leandro, Maria Terencio, Renata Lopes, Caroline Martins, et al. (+11)
6 [GO] 2021―Oct―27 MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation Yuting Jiang, Yuehong Chen, Hong Sun, Xiaolu Zhang, Lei He, Jiangfan Li, et al. (+2)
7 [GO] 2021―Oct―08 Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2 Laura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, et al. (+27)
8 [GO] 2021―Sep―15 Prevalence and molecular characteristics of feline coronavirus in southwest China from 2017 to 2020 Qun Zhou, Yan Li, Jian Huang, Nengsheng Fu, Xin Song, Xue Sha, Bin Zhang
9 [GO] 2021―Aug―23 Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present Phoebe Stevenson-Leggett, Stuart Armstrong, Sarah Keep, Paul Britton, Erica Bickerton
10 [GO] 2021―Jul―28 Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir Marie O. Pohl, Idoia Busnadiego, Francesco Marrafino, Lars Wiedmer, Annika Hunziker, Sonja Fernbach, et al. (+5)
11 [GO] 2021―Jun―16 Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom Joseph G. Chappell, Theocharis Tsoleridis, Gemma Clark, Louise Berry, Nadine Holmes, Christopher Moore, et al. (+18)
12 [GO] 2021―May―06 Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells Thrimendra Kaushika Dissanayake, Bingpeng Yan, Anthony Chin-Ki Ng, Hanjun Zhao, Gabriella Chan, Cyril Chik-Yan Yip, et al. (+2)
13 [GO] 2021―May―06 SARS-CoV-2 replicon for high-throughput antiviral screening Qiu-Yan Zhang, Cheng-Lin Deng, Jing Liu, Jia-Qi Li, Hong-Qing Zhang, Na Li, et al. (+5)
14 [GO] 2021―Apr―29 Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes Katherine Davies, Hubert Buczkowski, Stephen R. Welch, Nicole Green, Damian Mawer, Neil Woodford, et al. (+4)
15 [GO] 2021―Apr―23 Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2 Sophie J. Smither, Lin S. Eastaugh, James S. Findlay, Thomas R. Laws, Stephen N. Marriott, Stuart Notman, et al. (+7)
16 [GO] 2021―Apr―15 SARS-CoV-2 one year on: evidence for ongoing viral adaptation Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, Wendy S. Barclay
17 [GO] 2021―Apr―08 The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection Lisa Henss, Arne Auste, Christoph Schürmann, Christin Schmidt, Christine von Rhein, Michael D. Mühlebach, Barbara S. Schnierle
18 [GO] 2021―Feb―22 Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2 Elodie Monchatre-Leroy, Sandrine Lesellier, Marine Wasniewski, Evelyne Picard-Meyer, Céline Richomme, Franck Boué, et al. (+8)
19 [GO] 2021―Feb―15 A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India Asmita Gupta, Radhakrishnan Sabarinathan, Pratyusha Bala, Vinay Donipadi, Divya Vashisht, Madhumohan Rao Katika, et al. (+4)
20 [GO] 2021―Jan―28 Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19 Molly K. Roe, Nathan A. Junod, Audrey R. Young, Dia C. Beachboard, Christopher C. Stobart
21 [GO] 2021―Jan―11 A genetic element in the SARS-CoV-2 genome is shared with multiple insect species Torstein Tengs, Charles F. Delwiche, Christine Monceyron Jonassen
22 [GO] 2021―Jan―08 Assessment of inactivation procedures for SARS-CoV-2 Heidi Auerswald, Sokhoun Yann, Sokha Dul, Saraden In, Philippe Dussart, Nicholas J. Martin, et al. (+2)
23 [GO] 2020―Dec―17 Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit? Peter Simmonds, Sarah Williams, Heli Harvala
24 [GO] 2020―Nov―05 Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression Zhou Shen, Guangxu Zhang, Yilin Yang, Mengxia Li, Siqi Yang, Guiqing Peng
25 [GO] 2020―Sep―30 Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020 Mark Harris
26 [GO] 2020―Sep―09 Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus Arinjay Banerjee, Andrew C. Doxey, Benjamin J.-M. Tremblay, Michael J. Mansfield, Sonu Subudhi, Jeremy A. Hirota, et al. (+4)
27 [GO] 2020―Sep―09 Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses David A. Wilkinson, Léa Joffrin, Camille Lebarbenchon, Patrick Mavingui
28 [GO] 2020―Sep―07 Construction and efficacy evaluation of novel swine leukocyte antigen (SLA) class I and class II allele-specific poly-T cell epitope vaccines against porcine reproductive and respiratory syndrome virus Debin Tian, Sakthivel Subramaniam, C. Lynn Heffron, Hassan M. Mahsoub, Harini Sooryanarain, Bo Wang, et al. (+6)
29 [GO] 2020―Aug―21 SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients William B. Klimstra, Natasha L. Tilston-Lunel, Sham Nambulli, James Boslett, Cynthia M. McMillen, Theron Gilliland, et al. (+9)
30 [GO] 2020―Jul―28 Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virus Sarah Keep, Michael S. Oade, Filip Lidzbarski-Silvestre, Kirsten Bentley, Phoebe Stevenson-Leggett, Graham L. Freimanis, et al. (+6)
31 [GO] 2020―Jul―15 A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a Andrew E. Firth
32 [GO] 2020―Jun―24 Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems Severino Jefferson Ribeiro da Silva, Renata Pessôa Germano Mendes, Caroline Targino Alves da Silva, Alessio Lorusso, Alain Kohl, Lindomar Pena
33 [GO] 2020―Jun―15 Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection Jingfang Wang, Xintian Xu, Xinbo Zhou, Ping Chen, Huiying Liang, Xuan Li, et al. (+2)
34 [GO] 2020―May―20 The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection Paul Kellam, Wendy Barclay

34 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.014 sec